European Archives of Oto-Rhino-Laryngology

, Volume 270, Issue 2, pp 711–718

Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers

  • Coralia Bleotu
  • Mariana Carmen Chifiriuc
  • Raluca Grigore
  • Camelia Grancea
  • Cristian R. Popescu
  • Gabriela Anton
  • Costin Cernescu
Head and Neck


The aim of this study was to reveal the relationships between the features of the primary tumour, the degree of tumour stage, the presence of human papillomaviruses (HPV) in blood and the severity of Th1/Th2 serum cytokine imbalance in patients with laryngo-pharyngeal cancer. The study was performed on 50 patients (47 men and 3 women), with age ranging from 40 to 83 years (the mean of the patients’ ages was 58.4 ± 9.43 years, with a median of 60 years). A control group was represented by age-matched healthy patients (with no clinical diseases). The viral DNA was detected by PCR; the cytokine levels were determined by ELISA. A clear switch from cytokine Th1 to cytokine Th2 in cancer patients, low levels of IL-2 and IFNγ in advanced stages, as well as a positive correlation of increased levels of both IL-2 and IL-12 with the early stages of laryngo-pharyngeal cancer was observed. Loco-regional metastases were correlated with increased levels of IL-8 and IL-10 and drastic decrease of IFNγ. In advanced cancer stages, we found that the most affected were IL-2 and IFNγ correlated with increased levels of Th2 cytokines. Patients with HPV present in both primary tumours and blood showed increased values of IL-4:IL-2 ratio as compared with patients with HPV-positive primary tumours only, demonstrating the aggravation of the immunosuppressive state. The most important finding of our study is that for a correct evaluation of the Th1 to Th2 switch in cancer patients, it is necessary to establish not only the negative/positive correlations between different Th1 and Th2 type cytokines, but also the ratio between them. These parameters allowed us to state that the presence of HPV DNA in blood was associated with the most severe immunological imbalance that could potentially lead to a poor prognosis of these patients. Our findings encourage us to consider that the ratio between different Th1 and Th2 cytokines could represent a useful marker for clinical and pathological evaluation of cancer patients.


Th1/Th2 cytokine profile HPV infection Laryngeal/pharyngeal cancer Metastasis 


  1. 1.
    Reuter CWM, Morgan MA, Eckardt A (2007) Targeting EGF-receptor-signaling in squamous cell carcinomas of the head and neck. Br J Cancer 96:408–416PubMedCrossRefGoogle Scholar
  2. 2.
    Bray F, Sankila R, Ferlay J, Parkin DM (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99–166PubMedCrossRefGoogle Scholar
  3. 3.
    Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to loco-regional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. meta-analysis of chemotherapy on head and neck cancer. Lancet 355:49–955Google Scholar
  4. 4.
    Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328:184–194PubMedCrossRefGoogle Scholar
  5. 5.
    Löning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H (1985) Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 84:417–420PubMedCrossRefGoogle Scholar
  6. 6.
    Gillison ML, Koch WM, Shah KV (1999) Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 11:191–199PubMedCrossRefGoogle Scholar
  7. 7.
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720PubMedCrossRefGoogle Scholar
  8. 8.
    Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131PubMedCrossRefGoogle Scholar
  9. 9.
    Mao L, Hong WK (2004) How does human papillomavirus contribute to head and neck cancer development? J Natl Cancer Inst 96:978–980PubMedCrossRefGoogle Scholar
  10. 10.
    Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC (2001) Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 167:2972–2978PubMedGoogle Scholar
  11. 11.
    Shanmugaratnam S (1991) Histologic typing of tumors of the upper respiratory tract and ear. World Health Organization, Geneva (Switzerland)CrossRefGoogle Scholar
  12. 12.
    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRefGoogle Scholar
  13. 13.
    Svec A, Mikysková I, Hes O, Tachezy R (2003) Human papillomavirus infection of the epididymis and ductus deferens: an evaluation by nested polymerase chain reaction. Arch Pathol Lab Med 127:1471–1474PubMedGoogle Scholar
  14. 14.
    Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209–214Google Scholar
  15. 15.
    Atula S, Grenman R, Kujari H, Syrjänen S (1999) Detection of human papillomavirus (HPV) in laryngeal carcinoma cell lines provides evidence for a heterogeneic cell population. Eur J Cancer 35:825–832PubMedCrossRefGoogle Scholar
  16. 16.
    Clerici M, Shearer GM, Clerici E (1998) Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst 90:261–263PubMedCrossRefGoogle Scholar
  17. 17.
    Shurin MR, Shurin GV, Lokshin A, Yurkovetsky ZR, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL (2006) Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 25:333–356PubMedCrossRefGoogle Scholar
  18. 18.
    Kobayashi M, Kobayashi H, Pollard RB, Suzuki F (1998) A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol 160:5869–5873PubMedGoogle Scholar
  19. 19.
    Netea MG, Puren AJ, Dinarello CA (2000) A short course of oral aspirin increases IL-18-induced interferon-gamma production in whole blood cultures. Eur Cytokine Netw 11:379–382PubMedGoogle Scholar
  20. 20.
    Lathers DMR, Young MRI (2004) Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine 25:220–228PubMedCrossRefGoogle Scholar
  21. 21.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Roman JJ, Parham GP, Cannon MJ (2000) Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8 cytotoxic T lymphocytes. Lancet 355(9208):949–955Google Scholar
  22. 22.
    Tartour E, Fridman WH (1998) Cytokines and cancer. Int Rev Immunol 16:683–704PubMedCrossRefGoogle Scholar
  23. 23.
    Thiounn N, Mathiot C, Dorval T, Flam TA, Tartour E, Mosseri V, Zerbib M, Fridman WH, Debre B (1995) Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-alpha in the treatment of metastatic renal cell carcinoma. Br J Urol 75:586–589PubMedCrossRefGoogle Scholar
  24. 24.
    Lucey DR, Clerici M, Shearer GM (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9:532–562PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Coralia Bleotu
    • 1
    • 2
  • Mariana Carmen Chifiriuc
    • 2
  • Raluca Grigore
    • 3
  • Camelia Grancea
    • 1
  • Cristian R. Popescu
    • 3
  • Gabriela Anton
    • 1
  • Costin Cernescu
    • 1
  1. 1.Stefan S. Nicolau Institute of VirologyBucharestRomania
  2. 2.Faculty of BiologyUniversity of BucharestBucharestRomania
  3. 3.Colţea Clinic HospitalBucharestRomania

Personalised recommendations